India to Colombia: Heparin Export Trade Route

The India to Colombia Heparin corridor is one of India's established pharmaceutical export routes, with 48 shipments documented worth a combined $5.7M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's heparin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $119.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with heparin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 12.1%, placing it at rank #2 among India's top heparin export destinations globally.

On the import side, key buyers of Indian heparin in Colombia include NEXT PHARMA SOURCING S.A.S, NEXT PHARMA SOURCING, NEXT PHARMA SOURCING S.A.S and 3 others. NEXT PHARMA SOURCING S.A.S is the single largest importer with 35 shipments valued at $3.7M USD.

India's heparin exports to Colombia are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 30 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LTD, GLAND PHARMA LIMITED, GLAND PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $119.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as heparin injection bp, 25000iu/5ml,5ml vial and heparin injection bp25000iu/5ml5ml vial, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NEXT PHARMA SOURCING S.A.S is the largest importer with 35 shipments worth $3.7M USD — representing 65% of all heparin imports from India on this route. A total of 6 buyers are active on this corridor.